A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07549984 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07549984
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2027-02-10
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.